tiprankstipranks
Advertisement
Advertisement
Idexx Laboratories price target lowered to $660 from $790 at BofA
PremiumThe FlyIdexx Laboratories price target lowered to $660 from $790 at BofA
29d ago
Idexx Laboratories reports Q1 EPS $3.47, consensus $3.41
Premium
The Fly
Idexx Laboratories reports Q1 EPS $3.47, consensus $3.41
30d ago
Idexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80
Premium
The Fly
Idexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80
30d ago
Idexx Laboratories announces Idexx Cancer Dx Panel availability in the UK
PremiumThe FlyIdexx Laboratories announces Idexx Cancer Dx Panel availability in the UK
2M ago
Idexx Laboratories price target lowered to $675 from $775 at Stifel
Premium
The Fly
Idexx Laboratories price target lowered to $675 from $775 at Stifel
2M ago
Idexx Laboratories management to meet with Piper Sandler
Premium
The Fly
Idexx Laboratories management to meet with Piper Sandler
2M ago
Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler
PremiumThe FlyIdexx Laboratories price target lowered to $750 from $775 at Piper Sandler
4M ago
Idexx Laboratories price target lowered to $800 from $850 at Barclays
Premium
The Fly
Idexx Laboratories price target lowered to $800 from $850 at Barclays
4M ago
Idexx Laboratories price target lowered to $730 from $750 at UBS
Premium
The Fly
Idexx Laboratories price target lowered to $730 from $750 at UBS
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100